文献速递腹部MR

单发肝细胞癌患者术前预测早期复发可达到与术后评估相当的准确性

Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
PubMed 文献 · Korean J Radiol · 2020-01-01

本回顾性研究纳入549例米兰标准内单发肝细胞癌根治性切除患者,比较仅用术前因素与联合术前/术后因素预测早期复发的模型。仅术前模型(含Gd-EOB-DTPA增强MRI的动脉环状强化、非富血供肝胆期低信号结节等)的AUC为0.673,联合术后病理因素模型AUC为0.691,非劣效检验P=0.0013,提示仅基于术前影像和实验室因素的风险分层不劣于包含术后病理因素的分层。

要点

  • 术前Gd-EOB-DTPA增强MRI上动脉环状强化和非富血供肝胆期低信号结节是早期复发的独立预测因素。
  • 仅用术前因素预测早期复发的AUC为0.673,不劣于联合术后病理因素的AUC 0.691(非劣效检验P=0.0013)。
  • 术后加入微血管侵犯后,肿瘤大小不再显著(P=0.119),微血管侵犯成为额外显著因素(OR 1.868)。

核心结论

  • 仅基于术前影像和实验室因素的风险分层在预测米兰标准内单发肝细胞癌根治性切除后早期复发方面不劣于基于术后组织病理学危险因素的分层。

研究设计与样本

  • 回顾性研究,纳入549例因米兰标准内单发肝细胞癌接受根治性切除的患者。
  • 采用多因素分析筛选早期复发的高危因素,基于Akaike信息准则的逐步变量选择法分别构建仅术前因素模型和联合术前/术后因素模型。
  • 计算两模型ROC曲线下面积(AUC)并进行非劣效检验,采用bootstrap重抽样法进行内部验证。

关键影像表现/征象

  • 术前Gd-EOB-DTPA增强MRI上肿瘤动脉环状强化(OR 2.350;95% CI 1.297-4.260;P=0.005)和非富血供肝胆期低信号结节(OR 1.983;95% CI 1.049-3.750;P=0.035)与早期复发显著相关。
  • 术前因素中天冬氨酸氨基转移酶/血小板比值指数(OR 1.632;95% CI 1.056-2.522;P=0.027)和肿瘤大小(OR 1.025;95% CI 0.002-1.049;P=0.031)亦为显著因素。
  • 加入术后病理因素后,微血管侵犯成为额外显著因素(OR 1.868;95% CI 1.155-3.022;P=0.011),而肿瘤大小变为不显著(P=0.119)。

诊断标准与关键数值

  • 仅术前因素模型预测早期复发的AUC为0.673(95% CI 0.623-0.723)。
  • 联合术前/术后因素模型预测早期复发的AUC为0.691(95% CI 0.639-0.744)。
  • 两模型AUC比较的非劣效检验P=0.0013。

临床应用与阅片要点

  • 术前Gd-EOB-DTPA增强MRI上发现的动脉环状强化和非富血供肝胆期低信号结节可用于早期复发的术前风险分层。
  • 仅基于术前影像和实验室因素的预测模型与包含术后病理因素的模型在预测早期复发方面性能相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the performance of predicting early recurrence using preoperative factors only in comparison with using both pre-/postoperative factors.

MATERIALS AND METHODS: We retrospectively reviewed 549 patients who had undergone curative resection for single hepatcellular carcinoma (HCC) within Milan criteria. Multivariable analysis was performed to identify pre-/postoperative high-risk factors of early recurrence after hepatic resection for HCC. Two prediction models for early HCC recurrence determined by stepwise variable selection methods based on Akaike information criterion were built, either based on preoperative factors alone or both pre-/postoperative factors. Area under the curve (AUC) for each receiver operating characteristic curve of the two models was calculated, and the two curves were compared for non-inferiority testing. The predictive models of early HCC recurrence were internally validated by bootstrap resampling method.

RESULTS: Multivariable analysis on preoperative factors alone identified aspartate aminotransferase/platelet ratio index (OR, 1.632; 95% CI, 1.056-2.522; p = 0.027), tumor size (OR, 1.025; 95% CI, 0.002-1.049; p = 0.031), arterial rim enhancement of the tumor (OR, 2.350; 95% CI, 1.297-4.260; p = 0.005), and presence of nonhypervascular hepatobiliary hypointense nodules (OR, 1.983; 95% CI, 1.049-3.750; p = 0.035) on gadoxetic acid-enhanced magnetic resonance imaging as significant factors. After adding postoperative histopathologic factors, presence of microvascular invasion (OR, 1.868; 95% CI, 1.155-3.022; p = 0.011) became an additional significant factor, while tumor size became insignificant (p = 0.119). Comparison of the AUCs of the two models showed that the prediction model built on preoperative factors alone was not inferior to that including both pre-/postoperative factors {AUC for preoperative factors only, 0.673 (95% confidence interval [CI], 0.623-0.723) vs. AUC after adding postoperative factors, 0.691 (95% CI, 0.639-0.744); p = 0.0013}. Bootstrap resampling method showed that both the models were valid.

CONCLUSION: Risk stratification solely based on preoperative imaging and laboratory factors was not inferior to that based on postoperative histopathologic risk factors in predicting early recurrence after curative resection in within Milan criteria single HCC patients.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Cha DI, Jang KM, Kim SH, et al. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients. Korean J Radiol. 2020. PMID: 32193888. doi:10.3348/kjr.2019.0538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。